Name of Topic: Vaccine a boon COVID-19 pandemic
Description
Activity-The Massachusetts-based biotech company Modern Inc. is developing an RNA-based
vaccine, which is being called mRNA-1273. The company has already successfully completed
phase 1 trials of its vaccine candidate.
Complete the listed activity under following headings-
Step1- What is the objective/Aim.
Step 2- Represent one method by experiment or procedure (by drawing arts/sketch)
Step 3- Write the limitations and success of experimental observation.
Answers
Answer:
As more and more countries record the biggest single-day spikes in COVID-19 cases, the world is still grappling with the increasing terror of the novel coronavirus. The total number of infections worldwide has reached almost 5 million, including 3,24,000 fatalities. In between the growing death toll and the rate at which the infection is spreading, the medical staff are working day and night and toiling on front lines of the pandemic.
Even though experts across the globe are working round the clock to develop a potential vaccine, it is important to note that the development of a vaccine is a long process that goes through several stages of clinical trials. When a vaccine is injected in the body, it trains the body’s immune system to fight a particular pathogen. As of now, there are over 100 potential vaccines worldwide in different stages of development and the results of the US-based Moderna Therapeutics has been promising.